Search Results 2761-2770 of 16847 for Epilepsy (Partial Onset)

  1. Sleep disorders - Doctors and departments - Mayo Clinic

    ... Focal segmental glomerulosclerosis, Hypercalciuria ... D. Neurologist. Rochester, MN. Areas of focus: Dementia, Parkinson's disease, Early-onset ...

  2. Medical Research & Education - Mayo Clinic News Network

    Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. Study shows immune molecule may play key role ...

  3. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have identified a hidden "movement map" deep within the brain — a discovery that could help surgeons reduce side effects from epilepsy ...

  4. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have identified a hidden "movement map" deep within the brain — a discovery that could help surgeons reduce side effects from epilepsy ...

  5. Pediatric Neurosurgery - Clinical trials

    ... epilepsy. A Registry to Follow Long-Term Outcomes for Mother and Child Pairs After Fetal Surgery for Spina Bifida. Rochester, Minn. The purpose of this study ...

  6. Study To Assess Anti-CD38 Antibody Drug Conjugate In Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

    ... partial response (< PR) within 60 days of stopping prior therapy. For relapsing MM patients, the duration from the last dose of the last prior treatment ...

  7. Cisplatin, Intensity-Modulated Radiation Therapy, And Pembrolizumab In Treating Patients With Stage III-IV Head And Neck Squamous Cell Carcinoma - Mayo Clinic

    Activated Partial Thromboplastin Time (aPTT): =< 1.5 X ULN unless patient is ... duration of the trial, starting with the pre-screening or screening ...

  8. A Study To Evaluate EAA181 To Treat Newly-diagnosed Multiple Myeloma - Mayo Clinic

    About this study. The primary purpose of this study is to determine if bortezomib, daratumumab, lenalidomide and dexamethasone (Btz-DRd) consolidation ...

  9. A Study To Evaluate CB-839 HCl In Combination With Carfilzomib And Dexamethasone In Treating Patients With Recurrent Or Refractory Multiple Myeloma - Mayo Clinic

    ... duration of study participation, and 4 months after completion of CB-839 HCl, carfilzomib, and dexamethasone administration. Should a woman become pregnant ...

  10. Cochlear Implantation Among Adults and Older Children with Unilateral or Asymmetric Hearing Loss - Mayo Clinic

    18 years of age or older. · Hearing loss in the ear to be implanted must such that speech understanding is not possible with a well fitted hearing aid. · Onset of ...